Investors / Netherlands / Inkef
Inkef
Venture capital · Amsterdam, Netherlands · Europe
Inkef is an early-stage, hands-on investor that helps build companies. It posts news about its portfolio companies on LinkedIn.
Invests inHealthcare & Biotech
In its own wordsearly-stagehands-onlong-term
Your fit with Inkef
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsInkef lists 38 checked portfolio companies on its own site and is named in 5 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 40% of the companies with a known first round. Its largest themes are Healthcare & Biotech (33%), Fintech (15%) and AI & Machine Learning (11%). 30% of its companies are based in Netherlands. It invests most often alongside BioGeneration Ventures, General Catalyst and Peak.
Counts come from funding rounds that name Inkef, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Inkef's whole history. Rounds on record name 5 companies; its own site lists 38. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 40% |
| Series B | 40% |
| Growth | 20% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 1 | 1 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 3 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 76th | 38 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 78th | 11% of companies confirmed by a round |
| Sector focus | 62th | 33% in its largest sector |
| Reach | 95th | 10 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 33% | 15% |
| Fintech | 15% | 12% |
| AI & Machine Learning | 11% | 18% |
| Enterprise Software | 6% | 8% |
| Cybersecurity | 6% | 4% |
| E-commerce & Marketplaces | 6% | 6% |
| Industrial & Manufacturing | 4% | 7% |
| Legal & Compliance | 4% | 2% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| BioGeneration Ventures | 3 |
| General Catalyst | 3 |
| Peak | 3 |
| Category Ventures | 2 |
| Dolby Family Ventures | 2 |
| Droia Ventures | 2 |
| Index Ventures | 2 |
| Innovation Industries | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3592%
- No longer answers00%
- Points to another company38%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with BioGeneration Ventures
Compare Inkef head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Inkef| Date | Company | Stage |
|---|---|---|
| 29 Jul 2026 | Series B | |
| 7 May 2026 | Series C+ | |
| 5 Mar 2026 | Series B | |
| 1 Dec 2025 | Series A | |
| 20 May 2020 | Series A Led |
Round details for Inkef
Amounts, full round histories and every co-investor in Inkef's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
38 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
Healthcare & Biotech | Portfolio page | |||
| Aito provides a predictive database that gives instant, calibrated decisions learned from a company's own business data | AI & Machine LearningDeveloper Tools | Portfolio page | ||
| The company is developing a new class of medicines that can interact with previously undruggable targets | Healthcare & Biotech | Portfolio page | ||
| Anavo Therapeutics develops therapeutic programs using its IGNITE platform to target phosphatases for drug discovery | Healthcare & Biotech | Portfolio page | ||
| Audion Therapeutics is a clinical-stage company dedicated to the development of therapies to treat Hearing Loss | Healthcare & Biotech | Portfolio page | ||
| Baserow is a no-code open source database and application builder | EducationReal Estate & Construction | Portfolio page | ||
| Portfolio page | ||||
| The company delivers flowers and offers flower subscription services. | E-commerce & MarketplacesFood & Agriculture | Portfolio page | ||
| Castor provides a clinical trial platform for capturing, managing, and analyzing clinical data | Healthcare & Biotech | Portfolio page | ||
| ChannelEngine provides marketplace integration and multichannel ecommerce software | E-commerce & MarketplacesAI & Machine Learning | Portfolio page | ||
| Corporis Medical is a medical device company dedicated to developing and commercializing innovative healthcare solutions. | Healthcare & Biotech | Portfolio page | ||
| Draupnir Bio is developing oral, small molecule degraders of extracellular pathogenic proteins | Healthcare & Biotech | Portfolio page | ||
| The company provides a threat intelligence platform that offers contextual insights and prioritized intelligence to help businesses manage threats and make informed decisions. | CybersecurityAI & Machine Learning | Portfolio page | ||
| GitLab provides a platform for software engineering, including source code management, CI/CD, and security features. | Enterprise SoftwareCybersecurity | Portfolio page | ||
| Happeo provides an intranet platform for small and medium companies | EducationEnterprise Software | May 2020Series A | Page + round | |
| The company produces and sells an insulin patch pump for diabetes management. | Healthcare & Biotech | Portfolio page | ||
| iOnctura develops therapies for cancer and other diseases. | Healthcare & Biotech | Portfolio page | ||
| NMD Pharma discovers and develops novel therapeutics for neuromuscular diseases. | Healthcare & Biotech | Portfolio page | ||
| The company brings entrepreneurs and investors together for financing, impact and return. | Fintech | Portfolio page | ||
Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- inkef.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 20 May 2020
- Companies checked
- 38
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Inkef's profile as data
Pull Inkef's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/inkef.com
# also
GET /v1/firms/inkef.com/portfolio
GET /v1/firms/inkef.com/coinvestors
GET /v1/firms/inkef.com/news